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Abstract Fatty acid-binding proteins (FABPs) are 15-kDa
cytosolic proteins which are involved in the intracellular binding
and targeting of fatty acids. Some members have been implicated
in the regulation of cell growth and differentiation. In this study
we investigated the effect of a series of FABPs and heart FABP
(H-FABP) mutants on cell-free protein synthesis. Human
myelin, intestinal, heart and brain FABP showed a dose-
dependent inhibition of in vitro mRNA translation. Adipocyte,
liver and epidermal types had no effect. The inhibition was not
influenced by delipidation and for H-FABP mutants not related
to their affinity for fatty acids. Our results indicate that some
FABPs may modulate cell growth and/or differentiation by
inhibition of protein synthesis.
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1. Introduction
Fatty acid binding proteins (FABPs) are members of a
family of conserved intracellular lipid-binding proteins and
comprise at least eight types: liver (L-FABP), intestinal (I-
FABP), heart or muscle (H-FABP), adipocyte (A-FABP),
myelin (M-FABP), ileal (I-LBP), epidermal (E-FABP) and
brain (B-FABP) [1,2]. All FABPs are 14^16-kDa cytosolic
proteins and display sequence similarity of between 38 and
70%. The main function of FABP is thought to be intracel-
lular binding and targeting of fatty acids. They may also
modulate the e¡ect of fatty acids on various metabolic en-
zymes and receptors and on cellular processes as signal trans-
duction and gene expression.
Some members of the FABP family have been implicated in
the regulation of growth and di¡erentiation. Bovine mam-
mary-derived growth inhibitor (MDGI) which was identi¢ed
as a mixture of H-FABP and A-FABP [3], caused speci¢c
growth inhibition and terminal di¡erentiation of mammary
epithelial cells [4], and H-FABP cDNA transfection caused
a modest antiproliferative activity in human breast cancer
cells. Expression of bovine H-FABP in yeast inhibited cell
growth [5]. Changes in FABP content have been observed in
tumor cells, in an FABP type ^ and cell type ^ dependent way
[6^11]. Oka et al. reported the isolation and cloning of a 14-
kDa perchloric acid-soluble protein (PSP) from rat liver [12].
This protein exhibited a dose-dependent inhibition of mRNA
translation. Another PSP isolated from rat heart, identical to
H-FABP, also inhibited protein synthesis in vitro [13]. On the
basis of these observations we studied the e¡ect of a series of
FABPs (di¡erent in type, species, preparation, lipidation),
mutant FABPs and other proteins on in vitro mRNA trans-
lation.
2. Materials and methods
2.1. Materials
Human H-FABP, I-FABP, M-FABP and A-FABP were obtained
by recombinant expression and isolation, as described earlier by Veer-
kamp et al. [14]. Human B-FABP cDNA in pBluescript vector (ob-
tained from Dr. F. Shimizu, Otsuka GEN Research Institute, Kaga-
suno, Tokushima, Japan) was ampli¢ed and modi¢ed with PCR to
obtain NcoI and BamHI sites, checked on sequence in pCR 2.1 vector
and ligated in the pET-3d expression vector. B-FABP was expressed
in transformed BL21(DE3) cells and isolated as described for H-
FABP [14]. Human L-FABP was obtained by recombinant expres-
sion, according to the method described by Maatman et al. [15].
Recombinant human E-FABP and bovine H-FABP were obtained
from Dr. F. Spener (Dept. Biochemistry, University of Muºnster, Ger-
many) and Dr. C. Luºcke (Institute Biophysical Chemistry, Frankfurt,
Germany), respectively. Rat H-FABP and A-FABP were obtained by
recombinant expression and isolation as described by Prinsen and
Veerkamp [16]. Rat and porcine H-FABP were isolated from heart
tissue of these species as described previously [17]. Human H-FABP
mutants were obtained by oligonucleotide-directed in vitro mutagen-
esis and recombinant expression [18]. If indicated, FABPs were de-
lipidated by the Lipidex procedure [19]. All FABP preparations were
s 95% pure on the basis of SDS-PAGE and Coomassie brilliant blue
staining.
Bovine serum albumin (BSA), ovalbumin and horse heart myoglo-
bin were from Sigma, St. Louis, MO, USA; cytochrome c from Al-
drich, Milwaukee, MI, USA; RNasin from Promega, Madison, WI,
USA; rabbit reticulocyte lysate system, tobacco mosaic virus mRNA,
Xenopus L-globin mRNA and RNase A from Boehringer, Mannheim,
Germany; GF/C ¢lters from Whatman International, Maidstone,
UK; pCR2.1 vector from Invitrogen, Leek, the Netherlands. All other
reagents were of analytical grade.
2.2. Cell-free mRNA translation
Cell-free protein synthesis was carried out in the presence or ab-
sence of di¡erent FABP preparations, H-FABP mutants or other
proteins with a rabbit reticulocyte lysate assay system, containing
tobacco mosaic virus (TMV) mRNA. The kit instructions were basi-
cally followed, except that the incubation time was 45 min at 30‡C
and the TMV mRNA concentration was reduced to 24 Wg/ml. After
incubation, 4 Wl of the mixture were incubated with 0.5 ml 1 M NaOH
containing 5% (v/v) H2O2 for 10 min at 37‡C. Proteins were precipi-
tated by addition of 0.4 ml 50% trichloric acid (TCA)/2% (w/v) casein
and put on GF/C ¢lters. Filters were washed with 0.5% (w/v) TCA/10
mM Na4P2O7 and radioactivity was measured in a liquid scintillation
counter.
2.3. Assay for RNase activity
Various concentrations of RNase A or FABP were added to 250 Wl
of a solution containing 50 mM Tris-HCl (pH 7.5), 750 Wg total yeast
RNA, and the reaction mixture was incubated at 37‡C for 30 min.
The reaction was stopped by precipitation with 0.1 vol. of 3 M NaAc
(pH 5.2) and 2.5 vol. of 96% EtOH. RNA pellets were washed with
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70% EtOH, resolved in Milli Q and applied on 1.0% agarose gel
containing 0.003% ethidium bromide. After electrophoresis the
amount of RNA present in every lane was measured by densitometry.
3. Results
3.1. E¡ect of FABPs on cell-free protein synthesis
The e¡ect of FABPs on cell-free protein synthesis was ex-
amined in a rabbit reticulocyte lysate. Stimulation of trans-
lation by TMV mRNA amounted to 350-fold in control in-
cubations. At 150 Wg/ml, protein synthesis was inhibited to
about 30% and 40% by recombinant human B-FABP and
H-FABP, respectively (Table 1). Recombinant human M-
FABP and I-FABP inhibited protein synthesis almost com-
pletely, whereas human L-FABP, E-FABP and A-FABP did
not a¡ect protein synthesis. At 15 Wg/ml, the inhibitory e¡ect
of FABPs was less. Only human M-FABP inhibited protein
synthesis by 70% (Table 1). The same extent of inhibition was
caused by human M-FABP, I-FABP and H-FABP with Xeno-
pus L-globin mRNA instead of TMV mRNA, indicating that
inhibition by FABPs is not dependent on the mRNA type.
To examine the e¡ect of bound ligands on protein synthesis,
the e¡ect of delipidation was studied. Delipidation of re-
combinant M-FABP and I-FABP did not alter their inhibi-
tory e¡ect (Table 1). Several human H-FABP mutants with
di¡erent binding a⁄nities for oleic acid were also tested. Mu-
tants F57S, F4E, G67S and F4S have a high binding a⁄nity
for oleic acid (Kd values are 0.38, 0.39, 0.35 and 0.47 WM,
respectively), whereas mutants F16E and R106T do not bind
fatty acids or with very low a⁄nity. Mutants F57S, F16E and
R106T inhibited protein synthesis, whereas mutants F4E,
G67S and F4S did not a¡ect protein synthesis. Together,
these results indicate that there is no relation between protein
synthesis inhibition and bound ligands as fatty acids or bind-
ing activity.
Besides human recombinant FABP types, recombinant and
tissue-derived FABPs from other species were tested on their
ability to inhibit protein synthesis. Recombinant rat H-FABP
did not show any inhibition at 150 Wg/ml, whereas recombi-
nant bovine and human H-FABP inhibited by 75% and 62%,
respectively. In contrast to recombinant rat H-FABP, tissue-
derived rat H-FABP inhibited protein synthesis. Tissue-de-
rived porcine H-FABP did not show any inhibitory e¡ect.
Recombinant rat A-FABP had no e¡ect like human A-
FABP. Protein synthesis was not, or to a smaller extent, af-
fected by proteins like albumin, ovalbumin, myoglobin and
cytochrome c, indicating that inhibition of protein synthesis
is speci¢c for some FABPs.
Inhibition of protein synthesis by FABPs appeared to be
dose-dependent (Fig. 1). Recombinant human M-FABP ex-
hibited 50% inhibition (IC50) at 9.5 Wg/ml, whereas IC50 values
were 36 Wg/ml and 88 Wg/ml for recombinant human I-FABP
and H-FABP, respectively.
3.2. Test on RNase activity
Since contaminating RNase activity might cause the inhib-
ition, we determined the e¡ect of di¡erent RNase A concen-
trations on the translation assay (Fig. 1). Its IC50 value
amounted to 4.9 Wg/ml. This value is the same order of the
IC50 value for M-FABP. Subsequently we tested all FABP
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Table 1
E¡ect of di¡erent FABPs and other proteins on protein synthesis in a rabbit reticulocyte lysate system
Tested protein Protein concentration
150 Wg/ml 15 Wg/ml
M-FABP 0 (3) 31 þ 5 (3)
I-FABP 8 þ 2 (5) 92 þ 16 (4)
B-FABP 31 þ 11 (3) ^
H-FABP 38 þ 9 (8) 98 þ 7 (4)
A-FABP 89 þ 20 (4) ^
L-FABP 91 þ 24 (5) 95 þ 9 (3)
E-FABP 109 þ 4 (2) ^
M-FABP (delipidated) 0 (2) ^
I-FABP (delipidated) 16 þ 3 (2) ^
F57S H-FABP 28 þ 13 (3) ^
F16E H-FABP 31 þ 3 (2) ^
R106T H-FABP 57 þ 1 (2) ^
F4E H-FABP 82 þ 5 (3) ^
G67S H-FABP 106 þ 19 (3) ^
F4S H-FABP 114 þ 19 (3) ^
Bovine H-FABP 23 þ 1 (2) ^
Rat H-FABP 101 þ 3 (2) ^
Rat A-FABP 91 þ 10 (2) ^
Rat H-FABP (tissue) 12 þ 3 (3) ^
Porcine H-FABP (tissue) 103 þ 1 (2) ^
Cytochrome c 71 þ 7 (2) ^
Albumin 106 þ 3 (2) ^
Ovalbumin 111 þ 2 (2) ^
Myoglobin 133 þ 20 (3) ^
Translation was measured at 24 Wg/ml TMV mRNA in the absence or presence of 15 or 150 Wg/ml protein as described in Section 2, and expressed
as percentage of [35S]methionine incorporation of control without protein. Values are means þ S.D. (range) for the number of independent
experiments indicated. All FABP preparations are human, recombinant and undelipidated proteins, except otherwise indicated.
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solutions on the presence of RNase activity, by incubation
with yeast RNA and subsequent agarose gel electrophoresis.
RNase A clearly showed activity at a concentration of 1.5 Wg/
ml or higher, whereas all FABPs did not show any RNase
activity at a concentration of 150 Wg/ml protein. Densitometry
revealed that all FABP preparations showed about the same
density as the positive control which contained RNA only.
Even 1.5 mg/ml of human recombinant H-FABP did not
show any RNase activity. To con¢rm these data, the e¡ect
of RNasin in combination with RNase A or FABP on protein
synthesis was investigated. However, 2 U/Wl RNasin stimu-
lated the protein synthesis of the control by about 300%
and could therefore not be used to examine the presence of
RNase activity in FABP preparations.
4. Discussion
Several members of the FABP family are possibly involved
in the regulation of cell growth and di¡erentiation. In this
study we show that M-FABP, I-FABP, B-FABP and H-
FABP inhibit in vitro protein synthesis at physiological con-
centrations of about 1^10 WM. This inhibition appeared to be
dose-dependent and is not, or to a smaller extent, exhibited by
other proteins. Both agarose gel electrophoresis and the trans-
lation assay indicate that the FABPs do not contain RNase
activity. Rnase A and M-FABP have about the same IC50
value and the IC50 values of I-FABP and H-FABP are only
10-fold lower (Fig. 1), indicating that the inhibitory e¡ect of
the FABPs cannot be due to RNase contamination. These
¢ndings show that FABPs inhibit protein synthesis in the
rabbit reticulocyte cell-free lysate system in a di¡erent manner
from RNase A. The same ¢ndings were reported for rat liver-
and heart-derived perchloric acid-soluble protein (PSP)
[12,13]. It was also shown that these PSPs stimulated the dis-
aggregation of polyribosomes in the lysate, indicating that
they inhibit the initiation stage of the protein synthesis [12].
It remains to be investigated whether this is the same for
FABPs.
There seems to be no clear relation between protein syn-
thesis inhibition and FABP structure, isoelectric point, fatty
acid-binding activity or the presence of a ligand in the FABP
molecule. M-FABP and A-FABP with similar isoelectric
points and structure show a di¡erent action. Delipidation
has no e¡ect. H-FABP mutants F16E and R106T which
have low a⁄nity for oleic acid show the same inhibitory e¡ect
on protein synthesis as wild-type human H-FABP. However,
mutants with high a⁄nity for oleic acid have either no e¡ect
(F4S, F4E and G67S), or the same e¡ect as wild-type H-
FABP (F57S). Furthermore, delipidation of FABPs does not
alter their inhibitory e¡ect. Thus, it appears that the inhibi-
tory e¡ect is established by the FABP itself and not by its
bound ligand.
Interestingly, H-FABPs derived from di¡erent species did
not show the same e¡ect on protein synthesis. Both human
and bovine recombinant H-FABP inhibited protein synthesis
whereas rat recombinant H-FABP had no e¡ect. Surprisingly,
tissue-derived rat H-FABP had an inhibitory e¡ect, whereas
tissue-derived porcine H-FABP had not. We have no explan-
ation for these contrasting results.
Some members of the FABP family have been implicated in
the regulation of growth and di¡erentiation. Yeast, mouse
mammary epithelial cells and human breast cancer cell lines
showed a speci¢c inhibition of growth and exhibited a di¡er-
entiated morphology upon H-FABP cDNA transfection [5,6].
In agreement with these data, recombinant human and bovine
H-FABP and tissue-derived rat H-FABP inhibited cell-free
protein synthesis at physiological concentrations. Studies on
rat L6 muscle cells showed that A-FABP cDNA transfection
resulted in an increased growth but a decrease in di¡erentia-
tion [16], which may be in accordance with our observation
that A-FABP does not in£uence cell-free protein synthesis.
Although L-FABP plays an important role in the modulation
of mitogenesis of liver and hepatoma cells [20], addition of L-
FABP did not a¡ect cell-free protein synthesis in the system
we used. In conclusion, some members of the FABP family
possibly regulate cell proliferation and di¡erentiation by in-
teraction with the translation complex, although the mecha-
nism of this interaction remains to be investigated.
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